RNS Number : 6807G Renalytix PLC 31 March 2022 Renalytix plc ("Renalytix" or the "Company") Half Year Report LONDON and SALT LAKE CITY , March 31, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing
RNS Number : 5577G Renalytix PLC 30 March 2022 Renalytix plc ("Renalytix" or the "Company") Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors NEW YORK and SALT LAKE CITY , March 30, 2022 - Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces that, following the
RNS Number : 3159G Renalytix PLC 29 March 2022 Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes KidneyIntelX RAPID biobank program and partners on track to reach over 30,000 biospecimens with matched
RNS Number : 9571F Renalytix PLC 25 March 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31 NEW YORK and SALT LAKE CITY , March 25, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
RNS Number : 1092E Renalytix PLC 09 March 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health , and will
RNS Number : 6330C Renalytix PLC 24 February 2022 KidneyIntelX TM Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Care Data highlights strength of KidneyIntelX for clinical use in early-stage diabetic kidney
RNS Number : 3488C Renalytix PLC 22 February 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at Cowen 42 nd Annual Health Care Conference New York and SALT LAKE CITY , February 22, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) ("Renalytix" or the "Company") today
RNS Number : 3394C Renalytix PLC 22 February 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Appoint Timothy Scannell to Board of Directors NEW YORK, NY and SALT LAKE CITY, UT February 22, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced its intention to
RNS Number : 8956Z Renalytix PLC 27 January 2022 Renalytix plc ("Renalytix" or the "Company") Grant of Share Options New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that its Remuneration Committee has agreed to issue options over a total
RNS Number : 7789Z Renalytix PLC 27 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
